GlassScriptPhysician profile
Matthew J Bartow
NPI 1922460807
$1,732.74
in general payments reported to CMS, 2019-2025
12 companies · $847 in 2025
The $847 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $87.79 · 2023: $155 · 2024: $643 · 2025: $847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,536 · Consulting Fee: $80.00 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $29.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,535.95 |
| Consulting Fee | $80.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $29.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $425.96 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Acera Surgical, INC. | $222.44 | 2024-2025 | Restrata Wound Matrix |
| Organogenesis INC. | $205.23 | 2024-2025 | Puraply Wound Matrix |
| Abbvie INC. | $202.71 | 2024-2025 | |
| Motiva USA, LLC | $147.92 | 2025 | |
| Revance Therapeutics, INC. | $138.78 | 2025 | Daxi |
| Smith+Nephew, INC. | $136.62 | 2025 | Pico 14, Renasys Touch, Pico 7 |
| Davol INC. | $87.79 | 2022 | |
| Medtronic, INC. | $80.00 | 2023 | Lapro-Clip, Surgipro Ll |
| Eagle Pharmaceuticals, INC. | $30.65 | 2023 | |
| Becton, Dickinson and Company | $29.00 | 2024 | |
| Innovation Technologies INC | $25.64 | 2024 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Bartow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.